Skip to content

The external validation of a prediction model for anatomical cystocele recurrence after primary anterior colporrhaphy

The external validation of a prediction model for anatomical cystocele recurrence after primary anterior colporrhaphy - PARCC study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55841
Enrollment
260
Registered
2017-05-01
Start date
2017-07-11
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blaasverzakking pelvic floor dysfunction pelvic organ prolapse

Interventions

None listed

Sponsors

Maastricht Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All women who are planned for undergoing a primary anterior colporrhaphy because of a cystocele (with a POP-Q stage of 2 and higher) in the participating hospitals who are willing to participate in this study and give informed consent. Women need to be able to complete the questionnaires. A combination of a primary anterior colporrhaphy with other POP or incontinence surgery is permitted.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: -

Design outcomes

Primary

MeasureTime frame
The primary goal of this study is external validation of the prediction model for anatomical recurrence after primary anterior colporrhaphy. The main endpoint of this study is the calculated area under the curve (AUC) of the receiving operating curve (ROC).

Secondary

MeasureTime frame
The secundary goal is the identification of other risk factors besides the ones used in the prediction model for anatomical and subjective recurrence of cystocele after primary anterior colporrhaphy, calculated by univariate and multivariate regression analysis.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)